A New Tool to Assess Disease Severity in Eosinophilic Esophagitis.
Eosinophilic esophagitis
clinical tool
monitoring
outcomes
severity
treatment
Journal
Gastroenterology & hepatology
ISSN: 1554-7914
Titre abrégé: Gastroenterol Hepatol (N Y)
Pays: United States
ID NLM: 101262648
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
medline:
29
9
2023
pubmed:
29
9
2023
entrez:
29
9
2023
Statut:
ppublish
Résumé
The presentation of eosinophilic esophagitis (EoE) is heterogeneous with varied clinical, endoscopic, and histologic features impacting the severity of the condition. Until recently, however, and in contrast with many other conditions, there has been no standardized way to measure disease severity in EoE. A clinically applicable method for assessing severity in routine practice has been recognized as necessary to standardize assessment and management of EoE. Therefore, the American Gastroenterological Association has sponsored a consensus conference to determine elements of severity in EoE and develop the first tool to measure severity. This article presents details of this severity metric, which is known as the Index of Severity in EoE (I-SEE), and outlines the elements within I-SEE and how to categorize EoE as mild, moderate, severe, or inactive. The domains of I-SEE include symptoms and complications, inflammatory features (both endoscopic and histologic), and fibrostenotic features (both endoscopic and histologic). The article also provides an update on emerging data related to I-SEE and discusses the future studies necessary to implement I-SEE as part of a treatment framework in EoE.
Types de publication
Journal Article
Langues
eng
Pagination
457-462Informations de copyright
Copyright © 2023, Gastro-Hep Communications, Inc.
Références
Gastrointest Endosc. 2022 Jun;95(6):1126-1137.e2
pubmed: 35120883
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):479-490
pubmed: 28536485
Endoscopy. 2022 Jul;54(7):635-643
pubmed: 34674209
Aliment Pharmacol Ther. 2010 Dec;32(11-12):1373-82
pubmed: 21050240
Dis Esophagus. 2017 Feb 1;30(3):1-8
pubmed: 26857345
Gut. 2013 Apr;62(4):489-95
pubmed: 22619364
Clin Gastroenterol Hepatol. 2015 Mar;13(3):452-8
pubmed: 25086190
Dis Esophagus. 2020 May 07;:
pubmed: 32378700
Gastrointest Endosc. 2016 Jun;83(6):1142-8
pubmed: 26608127
Gastroenterology. 2022 Jul;163(1):59-76
pubmed: 35606197
Aliment Pharmacol Ther. 2013 Sep;38(6):634-42
pubmed: 23837796
Pediatr Allergy Immunol. 2017 Jun;28(4):312-319
pubmed: 28339136
Clin Gastroenterol Hepatol. 2016 Jan;14(1):31-9
pubmed: 26404868
Dis Esophagus. 2017 Jul 1;30(7):1-7
pubmed: 29206905
Case Rep Gastroenterol. 2017 Jun 15;11(2):382-388
pubmed: 29033756
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1475-1482.e1
pubmed: 31499251
Dig Liver Dis. 2022 Apr;54(4):477-482
pubmed: 34789398
Gastroenterology. 2014 Dec;147(6):1255-66.e21
pubmed: 25160980
Clin Gastroenterol Hepatol. 2023 Sep 22;:
pubmed: 37743034
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2526-2533
pubmed: 36572109
J Pediatr Gastroenterol Nutr. 2022 Feb 1;74(2):e31-e34
pubmed: 34620757
J Allergy Clin Immunol. 2022 Feb;149(2):659-670
pubmed: 34242635
Am J Gastroenterol. 2022 Feb 1;117(2):264-271
pubmed: 34797816
Dig Dis Sci. 2021 Feb;66(2):503-510
pubmed: 32166623
Gastroenterology. 2019 Jul;157(1):65-73.e5
pubmed: 30872104
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2489-2492.e1
pubmed: 34332949
Clin Gastroenterol Hepatol. 2021 Sep;19(9):1814-1823.e1
pubmed: 32707338
Gastrointest Endosc. 2014 Apr;79(4):577-85.e4
pubmed: 24275329
Gastroenterology. 2018 Oct;155(4):1022-1033.e10
pubmed: 30009819
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2534-2542.e1
pubmed: 37061110
Clin Gastroenterol Hepatol. 2018 Mar;16(3):305-310
pubmed: 29452645
Gastrointest Endosc. 2022 Oct;96(4):576-592.e1
pubmed: 35965102
Am J Gastroenterol. 2022 Feb 1;117(2):272-279
pubmed: 34932022
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2252-2259.e3
pubmed: 36410644
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2149-2160
pubmed: 30710696